Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lipodystrophy-Syndrome”

114 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 114 results

Post-approval studies (Phase 4)Ended earlyNCT00122668
What this trial is testing

Evaluation of the Occurrence of Lipoatrophy in HIV-1 Infected Naive Patients

Who this might be right for
HIV InfectionsHIV-Associated Lipodystrophy Syndrome
French National Agency for Research on AIDS and Viral Hepatitis 112
Not applicableStudy completedNCT05424913
What this trial is testing

Exploratory Study of the Relationships Between the Biomarkers of Inflammation, Lipidome and Insulin Resistance and Disorders of Glycemic Regulation in a Cohort of Insulin-resistant Subjects Due to Excess Weight or Dunnigan's Lipodystrophy

Who this might be right for
LipodystrophyDunnigan Syndrome
Centre Hospitalier Universitaire de la Réunion 150
Testing effectiveness (Phase 2)Study completedNCT00333684
What this trial is testing

Safety, Efficacy and Psychological Effects of Treating Antiretroviral Drug-Induced Facial Lipoatrophy With Bio-Alcamid

Who this might be right for
Human Immunodeficiency VirusFacial Lipoatrophy
Canadian Immunodeficiency Research Collaborative 36
Testing effectiveness (Phase 2)Study completedNCT00461552
What this trial is testing

Therapeutic Approaches to HAART-Induced Lipodystrophy

Who this might be right for
HIV InfectionsLipodystrophy
University of Texas Southwestern Medical Center 23
Large-scale testing (Phase 3)Study completedNCT01077765
What this trial is testing

Polyacrylamide Hydrogel Injection in HIV-related Lipoatrophy

Who this might be right for
HIV InfectionAntiretroviral Side EffectsLipodystrophy Syndrome Related to HIV Infection
Assistance Publique - Hôpitaux de Paris 100
Not applicableUnknownNCT00331448
What this trial is testing

Observational Study of Changes in Fat Distribution and Blood Metabolites in HIV Infected Adults

Who this might be right for
HIV InfectionsLipodystrophyDiabetes+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 1,483
Post-approval studies (Phase 4)Study completedNCT00389194
What this trial is testing

PREventing Progression of Adipose Tissue Redistribution

Who this might be right for
HIV Infections
International Antiviral Therapy Evaluation Center 120
Early research (Phase 1)Study completedNCT02342223
What this trial is testing

Voluma Filler Agent For The Treatment of HIV-associated Facial Lipoatrophy

Who this might be right for
HIV Facial Lipoatrophy
Jared Jagdeo, MD, MS 20
Post-approval studies (Phase 4)Study completedNCT00119769
What this trial is testing

The Effect of Low-Dose Human Growth Hormone Therapy in HIV Infected Patients

Who this might be right for
HIV InfectionsLipodystrophy
Hvidovre University Hospital 46
Post-approval studies (Phase 4)Study completedNCT01612858
What this trial is testing

Metabolic Abnormalities in HIV-infected Persons

Who this might be right for
LipodystrophyHIV Infection
Tufts Medical Center 20
Not applicableStudy completedNCT00015691
What this trial is testing

Metformin and Rosiglitazone, Alone or in Combination, in HIV-Infected Patients With Insulin and Fat Abnormalities

Who this might be right for
HIV InfectionsLipodystrophyHyperinsulinemia
National Institute of Allergy and Infectious Diseases (NIAID) 105
Not applicableStudy completedNCT01359917
What this trial is testing

Psychological Morbidity and Facial Volume in HIV Lipodystrophy: Quantification of Treatment Outcome

Who this might be right for
HIV-Associated Lipodystrophy Syndrome
NHS Lothian 50
Post-approval studies (Phase 4)Ended earlyNCT01031849
What this trial is testing

Analysis of Changes in Adipose Tissue of Patients With Lipoatrophy HIV Infection Treated With Nucleoside Thymidine, After Switching to Monotherapy With Lopinavir / Ritonavir

Who this might be right for
HIV Infections
Ines Perez 7
Post-approval studies (Phase 4)Study completedNCT04904406
What this trial is testing

Changes in Weight, Body Composition and Cardiac Risk After Discontinuing Abacavir Treatment in HIV-infected Individuals

Who this might be right for
HivHIV InfectionsHIV Cardiomyopathy+3 more
Thomas Benfield 81
Post-approval studies (Phase 4)Study completedNCT00005764
What this trial is testing

Increased Lactic Acid and Abnormal Fat Distribution in HIV-Positive Patients

Who this might be right for
HIV InfectionsLipodystrophy
Glaxo Wellcome 100
Early research (Phase 1)Study completedNCT01848340
What this trial is testing

Investigate the Recovery, Excretion, and Pharmacokinetics of 14C-GSK1265744 Administered as a Single Oral Dose and a Study to Describe the Pharmacokinetics of a Supratherapeutic Dose of GSK1265744 in Healthy Adult Subjects

Who this might be right for
HIV-associated Lipodystrophy Syndrome
ViiV Healthcare 16
Not applicableStudy completedNCT00312832
What this trial is testing

Study Comparing Reducing the Dose of Stavudine Versus Switching to Tenofovir in HIV-Infected Patients Receiving Antiretroviral Therapy

Who this might be right for
HIV InfectionsLipoatrophy
Hospital Clinic of Barcelona 60
Not applicableEnded earlyNCT02783417
What this trial is testing

Strength Training With Vascular Occlusion in Patients Harboring With HIV/Aids

Who this might be right for
Cardiovascular Diseases
University of Sao Paulo 22
Post-approval studies (Phase 4)Study completedNCT00646984
What this trial is testing

Strategies of Interruption/Reinitiation of Antiretroviral Therapy in HIV-Infected Patients With Lipodystrophy

Who this might be right for
HIV-Associated Lipodystrophy Syndrome
Hospital Clinic of Barcelona 147
Post-approval studies (Phase 4)UnknownNCT04903847
What this trial is testing

Changes in Weight, Body Composition and Metabolic Parameters After Discontinuing Dolutegravir or Tenofovir Disproxil

Who this might be right for
HivHIV InfectionsHIV Lipodystrophy+4 more
Thomas Benfield 126
Next Page